Ab externo microshunt shows promising 1-year outcomes

Investigators examined 1-year outcomes of a novel standalone SIBS microshunt (Preserflo) with mitomycin C.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553